CETENE S.A. - Centro de Nefrologia y Dialisis

San Miguel de Tucumán T4000IIO

0 studies enrolling now · 1 studies all time

What they study most

Diabetic Nephropathy

Studies at this site

• A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy — Completed